Feedback on Hematopoietic Cell Therapy Standards Requested
The Foundation for the Accreditation of Cellular Therapy (FACT) and the Joint Accreditation Committee of ISCT-EBMT (JACIE) have published the draft 7th edition of the FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration for inspection and public comment for a 90-day period. Comments will be accepted from May 1, 2017 through July 30, 2017.
These Standards apply to all phases of collection, processing, storage, and administration of hematopoietic cellular therapy products. This includes hematopoietic progenitor cells (HPCs), mononuclear cells (MNCs), and immune effector cells (IECs) derived from marrow, apheresis, or cord blood, and administered by a FACT or JACIE-accredited blood and marrow transplant team.
Description and Instructions for FACT-JACIE Standards
Draft FACT-JACIE Standards
Draft FACT-JACIE Manual
To submit comments regarding the draft 7th edition FACT-JACIE Standards, follow the steps below. Comments will be accepted through July 30, 2017.
- Access the Comment Form at https://www.surveymonkey.com/r/FACT-JACIE.
- Type in your contact information and comments on the form. Fill in all fields so that the Standards Committee fully understands your position.
- Submit the form when finished. Once the form is submitted, it cannot be changed. However, additional comments may be submitted by completing the form again. There is no limit to the number of forms that can be submitted.
FACT and ASGCT Webinar Collaboration: Cytokine Release Syndrome
Wednesday, June 28, 2017
Join FACT and ASGCT on Wednesday, June 28, 2017, at 11:00 ET. Marco Davila, MD, PhD, of the H. Lee Moffitt Cancer Center and Research Institute, and Marcela Maus, MD, PhD, of the Massachusetts General Hospital Cancer Center and Harvard University, will explain the diagnostic criteria, various grading schemes, major medical interventions available, and the risks of cytokine release syndrome.
View meeting details and register online
FACT Concludes Quality Management Series Module 7: Outcome Analysis -
Recordings Available!
The seventh Quality Management Series module included four sessions on outcome analysis related to cellular therapy programs and cord blood banks. If you did not get a chance to attend these webinars live, you may still view the recordings. Purchase the entire module to receive a 15 percent discount!
Purchase the QM Series Module 7: Outcome Analysis
Sessions within the module are also available for individual purchase and include:
Benchmarking Clinical Outcomes (November 30, 2017)
Making Outcome Analyses Work for You (January 25, 2017)
Improving Our Clinical Outcomes Virtual Roundtable (February 8, 2017)
Completing FACT-Required Outcome Analyses (March 22, 2017)
Other ASBMT News Sources: